Lucy Johnson-Cameron

Lucy Johnson-Cameron’s practice is broad covering a range of corporate transactions, including domestic and cross-border M&A, joint ventures and corporate advisory work. Lucy has represented clients in a variety of industry sectors, including technology and real estate, with a particular interest and focus on life sciences and healthcare. Lucy has undertaken a secondment at a biopharmaceutical client and also actively takes on pro bono work.

Prior to joining the firm, Lucy practiced with an American firm in London.

Experience

McArthurGlen and the Outlet Site Group on numerous matters, including (i) its joint venture investments in a number of retail outlet centres in the UK and Europe; (ii) the redeployment of cash throughout the corporate structure; (iii) an upstream merger of two Luxembourg companies, Outlet Site Holdings Sarl and Outlet Site JV Sarl.
Founders and owners of Broadberry Data Systems Limited, a leading manufacturer of high-end custom rackmount servers, storage servers and high-performance workstations, in its sale to Source Code LLC.
McArthurGlen and the Outlet Site Group on the corporate aspects of an upstream merger of two Luxembourg companies, Outlet Site Holdings Sarl and Outlet Site JV Sarl.
Diversis Capital UK Limited, on its recommended cash offer for ServicePower Technologies plc.
Major UK insurance claims technology company in connection with various strategic acquisitions and investments for an aggregate purchase price of £150 million.

Leading international cable company on its acquisition of a Puerto Rico cable operator for an enterprise value of US$272.5 million.
Leading AIM-listed insurance technology company on an institutional placing raising £200 million.
Advised the nominated advisor and broker on the admission to AIM of the UK's first crowd funded company listed on the main UK stock exchange and the first mainstream buy-to-let REIT specialising in residential property.
Leading insurance technology company on its telematics joint venture with a leading British automotive services company for a combined initial investment of £30 million and advised on the subsequent termination of the joint venture.

AstraZeneca, in agreements with governmental authorities for the distribution of the University of Oxford's COVID-19 vaccine.
Pfizer, in agreements for the supply to various governmental authorities of Pfizer and BioNTech’s mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2.
Omega Healthcare Investors, Inc., in a number of transactions concerning its acquisition and lease of UK healthcare facilities.
Amicus Therapeutics, Inc., on the establishment of its European operations and providing ongoing corporate advisory work.
The Association of the British Pharmaceutical Industry on its conversion to a company limited by guarantee.

Advising on a tri-party charity merger, aimed at providing a key community hub in an area of Bristol through a community centre and an adventure playground.
Advising on the establishment and registration of several Charitable Incorporated Organisations, including an organisation providing teachers in rural areas of Uganda and an organisation supporting women and children though creative and cultural art in the Aida refugee camp in Bethlehem.

Perspectives

February 9, 2021

Drafting Warranties and Disclosure Provisions: A Reminder of the Importance of Clear Provisions

Advisory

Credentials

Education

Graduate Diploma in Law, BPP Law School, 2009
Legal Practice Course, BPP Law School, 2010
BA, University of Sussex, 2008

Admissions

England and Wales

Experience

Perspectives

Credentials

Email Disclaimer